Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
The primary objective of the study is to evaluate the impact on quality of life of Lanreotide Autogel 120 mg in combination with standard care, in comparison to the standard care alone, in subjects affected by inoperable malignant bowel obstruction.
Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
- 09 Octobre 2024 - 1 mn de lecture
The primary objective of the study is to evaluate the impact on quality of life of Lanreotide Autogel 120 mg in combination with standard care, in comparison to the standard care alone, in subjects affected by inoperable malignant bowel obstruction.
En rapport Clinical Trials
09 Octobre 2024
1 mn de lecture
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
09 Octobre 2024
1 mn de lecture
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
09 Octobre 2024
1 mn de lecture
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
09 Octobre 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
09 Octobre 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Follow-on Study
09 Octobre 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Study
09 Octobre 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Study
09 Octobre 2024
1 mn de lecture
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
09 Octobre 2024
1 mn de lecture
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
09 Octobre 2024
1 mn de lecture